Iatrogenic transmission of human T cell lymphotropic virus type 1 and hepatitis C virus through parenteral treatment and chemoprophylaxis of sleeping sickness in colonial Equatorial Africa

Clinical Infectious Diseases

Volumn 51, Issue 7, 2010, Pages 777-784

  Pépin, Jacques ^a   Labbé, Annie Claude ^b   Mamadou Yaya, Fleurie ^c   Mbélesso, Pascal ^c   Mbadingaï, Sylvestre ^c   Deslandes, Sylvie ^a   Locas, Marie Claude ^b   Frost, Eric ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c University of Bangui   (Central African Republic)

Author keywords

[No Author keywords available]

Indexed keywords

PENTAMIDINE;

ADULT; AFRICA; AFRICAN TRYPANOSOMIASIS; AGED; ARTICLE; CHEMOPROPHYLAXIS; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; TROPICAL DISEASE; VIRUS TRANSMISSION; VIRUS VIRULENCE;

AGED; ANTIBODIES, VIRAL; ANTIPROTOZOAL AGENTS; CENTRAL AFRICAN REPUBLIC; CHEMOPREVENTION; CROSS-SECTIONAL STUDIES; HEPACIVIRUS; HEPATITIS C; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IATROGENIC DISEASE; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; TRYPANOSOMIASIS, AFRICAN;

EID: 77957852319     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656232     Document Type: Article

References (34)

1. Worobey M, Gemmel M, Teuwen DE, et al. Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008; 455:661-664.
2. Lemey P, Pybus OG, Wang B, Saksena NK, Salemi M, Vandamme AM. Tracing the origin and history of the HIV-2 epidemic. Proc Natl Acad Sci U S A 2003; 100:6588-6592.
3. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355:887-891.
4. US Census Bureau. HIV/AIDS surveillance database. Washington, DC: US Census Bureau, September 2004.
5. Pepin J, Plamondon M, Alves A, Beaudet M, Labbé AC. Parenteral transmission during excision and treatment of tuberculosis and trypanosomiasis may be responsible for the HIV-2 epidemic in Guinea-Bissau. AIDS 2006; 20:1303-1311.
6. Gao F, Bailes E, Robertson DL, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999; 397:436-441.
7. Neel C, Etienne L, Li Y, et al. Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas. J Virol 2010; 84:1464-1476.
8. Pépin J, Labbé AC. Noble goals, unforeseen consequences: the control of tropical diseases in colonial Central Africa and the iatrogenic transmission of blood-borne viruses Trop Med Int Health 2008; 13:744-753.
9. Lotte AJ. Historique du foyer de trypanosomiase de Nola. Bull Soc Pathol Exot 1953; 46:374-386.
10. Le Gac P. La trypanosomiase en Oubangui-Chari. Le foyer de Nola, sa chimioprophylaxie par la pentamidine et la Lomidine. Bull Soc Pathol Exot 1951; 44:488-494.
11. Lotte AJ. Enseignement de quatre années de chimioprophylaxie en AEF. Med Trop 1951; 11:737-766.
12. Lotte AJ. Essai de codification de la prophylaxie chimique de la maladie du sommeil. Med Trop 1953; 13:888-948.
13. Afrique Équatoriale Française. Oubangui-Chari. Année 1932. Rapport Médical Annuel. Marseilles, France: Institut de Médecine Tropicale du Service de Santé des Armées, 1932.
14. Afrique Équatoriale Française. Gouvernement Général. Inspection Générale des Services Sanitaires Médicaux et Civils. Rapport Médical Annuel 1933. Oubangui-Chari. Marseilles, France: Institut de Médecine Tropicale du Service de Santé des Armées, 1933.
15. Afrique Équatoriale Française. Territoire de l'Oubangui-Chari. Service de Santé. Rapport Médical. Année 1945. Marseilles, France: Institut de Médecine Tropicale du Service de Santé des Armées, 1945.
16. Territoire de l'Oubangui-Chari. Rapport Annuel 1946. Marseilles, France: Institut de Médecine Tropicale du Service de Santé des Armées, 1946.
17. Territoire de l'Oubangui-Chari. Rapport Annuel 1948. Marseilles, France: Institut de Médecine Tropicale du Service de Santé des Armées, 1948.
18. Afrique Équatoriale Française. Service Géné ral d'Hygiène Mobile et de Prophylaxie. Rapport Annuel. Marseilles, France: Institut de Médecine Tropicale du Service de Santé des Armées, 1948.
19. Jamot E. La lutte contre la maladie du sommeil au Cameroun. Ann Inst Pasteur 1932; 48:481-539.
20. Jamot E. Essai de prophylaxie médicale de la maladie du sommeil dans l'Oubangui-Chari. Bull Soc Pathol Exot 1920; 13:343-376.
21. Njouom R, Frost E, Deslandes S, et al. Predominance of hepatitis C genotype 4 infection and rapid transmission between 1935 and 1965 in the Central African Republic. J Gen Virol 2009; 90:2452-2456.
22. Sintasath DM, Wolfe ND, Lebreton M, et al. Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon. Emerg Infect Dis 2009; 15:175-184.
23. Giles-Vernick T. Cutting the vines of the past: environmental histories of the Central African rain forest. Charlottesville: University Press of Virginia, 2002.
24. Jagger J. Occupational transmission of hepatitis C virus. JAMA 2002; 288:1469-1470.
25. Muraz G. État actuel des traitements chimiothérapiques de la maladie du sommeil. In: Les grandes endémies tropicales. Paris: Vigot Frères, 1933.
26. Waddy BB. Chemoprophylaxis of human trypanosomiasis. In: Mulligan HW, Potts WH, eds. The African trypanosomiases. London: George Allen and Unwin, 1970.
27. Mahieux R, Ibrahim F, Mauclère P, et al. Molecular epidemiology of 58 new HTLV-1 strains: identification of a new and distinct HTLV-1 molecular subtype in Central African and in Pygmies. J Virol 1997; 71:1317-333.
28. Louis J, Gardon J, Trebucq A, Hengy C, Louis F, Migliani R. Particularités épidémiologiques de l'infection rétrovirale à HTLV-1 en Afrique centrale. Bull Soc Pathol Exot 1993; 86:163-168.
29. Le Hesran JY, Delaporte E, Gaudebout C, et al. Demographic factors associated with HTLV-1 infection in a Gabonese community. Int J Epidemiol 1994; 23:812-817.
30. Delaporte E, Buvé A, Nzila N, et al. HTLV-1 among prostitutes and pregnant women in Kinshasa, Zaire: how important is high risk sexual behaviour? J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8:511-515.
31. Lechat MF, Shrager DI, Declercq E, Bertrand F, Blattner A, Blumberg BS. Decreased survival of HTLV-1 carriers in leprosy patients from the Democratic Republic of the Congo: a historical prospective study. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:387-390.
32. Madhava V, Burges C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002; 2:293-302.
33. Pepin J, Lavoie M, Pybus OG, et al. Risk factors for hepatitis C virus transmission in colonial Cameroon. Clin Infect Dis 2010; 51(7):768-776 (in this issue).
34. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006; 368:938-945.